Aptus Capital Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.4K Hold
206
– – ﹤0.01% 1489
2026
Q2
$24.4K Buy
206
+1
+0.5% +$108 ﹤0.01% 1491
2026
Q1
$21.3K Hold
205
– – ﹤0.01% 1393
2025
Q4
$21.4K Buy
205
+1
+0.5% +$101 ﹤0.01% 1404
2025
Q3
$18.9K Hold
204
– – ﹤0.01% 1356
2025
Q2
$16.3K Buy
204
+1
+0.5% +$80 ﹤0.01% 1316
2025
Q1
$17.6K Buy
203
+1
+0.5% +$85 ﹤0.01% 1228
2024
Q4
$16.7K Hold
202
– – ﹤0.01% 1237
2024
Q3
$17.6K Buy
202
+1
+0.5% +$86 ﹤0.01% 1055
2024
Q2
$16.5K Hold
201
– – ﹤0.01% 992
2024
Q1
$16.1K Buy
201
+1
+0.5% +$77 ﹤0.01% 992
2023
Q4
$15.2K Buy
200
+25
+14% +$1.79K ﹤0.01% 768
2023
Q3
$12.7K Hold
175
– – ﹤0.01% 784
2023
Q2
$13.2K Buy
+175
New +$13.4K ﹤0.01% 678
2023
Q1
– Sell
-175
Closed -$13.8K – 863
2022
Q4
$13.8K Hold
175
– – ﹤0.01% 675
2022
Q3
$12K Buy
+175
New +$13.1K ﹤0.01% 648

Other funds holding PJP

Aptus Capital Advisors's PJP Position: Q3 2026 in Review

Aptus Capital Advisors held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2026 at 206 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1489.

Aptus Capital Advisors first reported a position in PJP in Q3 2022 and has held it in 16 quarters since. 135 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

  • Aptus Capital Advisors held 206 shares of Invesco Pharmaceuticals ETF worth $25.4K as of Q3 2026.
  • Aptus Capital Advisors left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q3 2026, its #1489 holding.
  • Aptus Capital Advisors first reported a position in Invesco Pharmaceuticals ETF in Q3 2022 and has held it in 16 quarters since.
  • 135 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Aptus Capital Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.